Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction [13]

Kidney International

Volumn 68, Issue 3, 2005, Pages 1375-1376

  Nakao, Naoyuki ^a,b   Sakai, Makoto ^a   Fujimori, Akira ^a   Fukagawa, Masfumi ^a  

^a Dialysis Center ^*

^b Division of Nephrology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANDOLAPRIL;

BLOOD PRESSURE MONITORING; CHRONIC KIDNEY DISEASE; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; HUMAN; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZATION; TREATMENT INDICATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION, RENAL; RENAL INSUFFICIENCY, CHRONIC;

EID: 32644472992     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00536_13.x     Document Type: Letter

References (3)

1. WOLF G, RITZ E: Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications. Kidney Int 67:799-812, 2005
2. NAKAO N, YOSHMURA A, MORITA H, et al: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial. Lancet 361:117-124, 2003
3. NAKAO N, SENO H, KASUGA H, et al: Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: A COOPERATE-ABP substudy. Am J Nephrol 24:543-548, 2004